题名 | Phase 1 clinical trial demonstrated that MUC1 positive metastatic seminal vesicle cancer can be effectively eradicated by modified Anti-MUC1 chimeric antigen receptor transduced T cells. |
链接 | http://www.ncbi.nlm.nih.gov/pubmed/26961900 |
欢迎光临 科研速递论坛 (http://expaper.cn/) | Powered by Discuz! X2.5 |